157 related articles for article (PubMed ID: 21610708)
1. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
Böckelman C; Hagström J; Mäkinen LK; Keski-Säntti H; Häyry V; Lundin J; Atula T; Ristimäki A; Haglund C
Br J Cancer; 2011 Jun; 104(12):1890-5. PubMed ID: 21610708
[TBL] [Abstract][Full Text] [Related]
2. The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma.
Seppälä M; Tervo S; Pohjola K; Laranne J; Huhtala H; Toppila-Salmi S; Paavonen T
APMIS; 2015 Dec; 123(12):1007-15. PubMed ID: 26522733
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
4. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
5. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
8. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue.
Bello IO; Vilen ST; Niinimaa A; Kantola S; Soini Y; Salo T
Hum Pathol; 2008 Aug; 39(8):1212-20. PubMed ID: 18547615
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of CIP2A expression in serous ovarian cancer.
Böckelman C; Lassus H; Hemmes A; Leminen A; Westermarck J; Haglund C; Bützow R; Ristimäki A
Br J Cancer; 2011 Sep; 105(7):989-95. PubMed ID: 21897396
[TBL] [Abstract][Full Text] [Related]
10. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
11. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
[TBL] [Abstract][Full Text] [Related]
13. CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C
Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977
[TBL] [Abstract][Full Text] [Related]
14. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.
Almangush A; Bello IO; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Nieminen O; Soini Y; Kosma VM; Koivunen P; Grénman R; Leivo I; Salo T
Head Neck; 2014 Jun; 36(6):811-8. PubMed ID: 23696499
[TBL] [Abstract][Full Text] [Related]
15. CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.
Rantanen T; Kauttu T; Åkerla J; Honkanen T; Krogerus L; Salo J; Paavonen T; Oksala N
Med Oncol; 2013; 30(3):684. PubMed ID: 23925667
[TBL] [Abstract][Full Text] [Related]
16. CIP2A is overexpressed in esophageal squamous cell carcinoma.
Qu W; Li W; Wei L; Xing L; Wang X; Yu J
Med Oncol; 2012 Mar; 29(1):113-8. PubMed ID: 21140243
[TBL] [Abstract][Full Text] [Related]
17. Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma.
Almahmoudi R; Salem A; Sieviläinen M; Sundquist E; Almangush A; Toppila-Salmi S; Paavonen T; Salo T; Al-Samadi A
Head Neck; 2018 Oct; 40(10):2155-2165. PubMed ID: 29761594
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.
Lim SC; Zhang S; Ishii G; Endoh Y; Kodama K; Miyamoto S; Hayashi R; Ebihara S; Cho JS; Ochiai A
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):166-72. PubMed ID: 14734465
[TBL] [Abstract][Full Text] [Related]
20. CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.
Chao TT; Maa HC; Wang CY; Pei D; Liang YJ; Yang YF; Chou SJ; Chen YL
APMIS; 2016 Dec; 124(12):1031-1037. PubMed ID: 27649840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
